To further study the efficiency of N-cadherin-targeted therapy, we injected mice with ADH-1. hematopoietic stem cells into the tail vein to MLLT3 evaluate whether the N-cadherin antagonist N-Ac-CHAVC-NH2 (designated ADH-1) could improve the therapeutic effect of tumor-infiltrating lymphocyte (TIL)-related treatment. Results N-cadherin dramatically upregulated the expression of PD-L1 and IDO-1 […]